51³Ô¹ÏÍø

Congressman Smith supports amici brief in mifepristone Supreme Court challenge

New Jersey Congressman Chris Smith says at a news conference days before oral arguments in FDA versus Alliance for Hippocratic Medicine before the supreme court that the FDA's decision to remove the requirement for an office visit before taking chemical abortion drugs has led to significant safety concerns, including the risk of underreporting adverse events and the inability to assess whether there is an ectopic pregnancy.
New Jersey Congressman Chris Smith says at a news conference days before oral arguments in FDA versus Alliance for Hippocratic Medicine before the supreme court that the FDA's decision to remove the requirement for an office visit before taking chemical abortion drugs has led to significant safety concerns, including the risk of underreporting adverse events and the inability to assess whether there is an ectopic pregnancy.
PURCHASE A LICENSE

Get personalized pricing by telling us when, where, and how you want to use this asset.

DETAILS

Restrictions:
May not be used as partisan political campaign material to promote or oppose the candidacy of any person for elective public office, and may not be used to distort the objects and purposes of the hearing, or cast discredit on or dishonor any member of the U.S. House of Representatives or U.S. Senate, or bring the House or Senate or any Member into disrepute.
Credit:
FedNet / Getty Images
Editorial #:
2111691292
Collection:
FedNet
Date created:
March 21, 2024
Upload date:
License type:
Rights-ready
Release info:
Not released.ÌýMore information
Clip length:
00:00:57:25
Location:
Washington, DC, United States
Mastered to:
MPEG-4 8-bit H.264 HD 1920x1080 29.97p
Source:
FedNet
Object name:
hpr032124cb